🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/06/2022 | 92,31 | 92,98 | 91,89 | 92,51 | +0,67% | 1,18% | 8.657.100 |
| 28/06/2022 | 94,11 | 94,33 | 91,47 | 91,89 | -2,67% | 3,04% | 13.523.300 |
| 27/06/2022 | 93,20 | 95,72 | 93,05 | 94,41 | +1,37% | 2,86% | 11.949.000 |
| 24/06/2022 | 93,25 | 93,79 | 91,70 | 93,13 | +1,23% | 2,24% | 25.248.400 |
| 23/06/2022 | 90,00 | 92,15 | 89,56 | 92,00 | +3,19% | 2,88% | 14.718.400 |
| 22/06/2022 | 88,04 | 90,34 | 88,03 | 89,16 | +1,28% | 2,62% | 11.935.400 |
| 21/06/2022 | 86,05 | 88,36 | 85,27 | 88,03 | +4,03% | 3,59% | 11.778.600 |
| 17/06/2022 | 84,64 | 85,76 | 83,39 | 84,62 | -0,32% | 2,80% | 32.989.100 |
| 16/06/2022 | 83,77 | 85,19 | 83,05 | 84,89 | +0,31% | 2,55% | 12.925.200 |
| 15/06/2022 | 84,56 | 85,37 | 83,75 | 84,63 | +0,15% | 1,92% | 11.357.100 |
| 14/06/2022 | 84,77 | 85,04 | 83,87 | 84,50 | -0,59% | 1,38% | 11.226.900 |
| 13/06/2022 | 85,71 | 86,51 | 84,63 | 85,00 | -2,50% | 2,19% | 12.016.100 |
| 10/06/2022 | 87,17 | 88,04 | 86,71 | 87,18 | -0,93% | 1,53% | 8.861.600 |
| 09/06/2022 | 89,25 | 89,79 | 87,92 | 88,00 | -1,65% | 2,10% | 7.381.100 |
| 08/06/2022 | 90,58 | 90,65 | 89,27 | 89,48 | -1,11% | 1,52% | 10.266.000 |
| 07/06/2022 | 90,15 | 90,82 | 89,58 | 90,48 | +0,71% | 1,38% | 10.243.300 |
| 06/06/2022 | 90,17 | 90,66 | 89,69 | 89,84 | -0,08% | 1,08% | 8.336.900 |
| 03/06/2022 | 89,74 | 90,68 | 89,68 | 89,91 | -0,10% | 1,11% | 7.051.600 |
| 02/06/2022 | 91,13 | 91,14 | 88,74 | 90,00 | -1,25% | 2,63% | 11.066.200 |
| 01/06/2022 | 91,67 | 91,93 | 90,04 | 91,14 | -0,97% | 2,06% | 10.492.500 |
| 31/05/2022 | 91,91 | 92,62 | 90,87 | 92,03 | -1,13% | 1,90% | 22.860.800 |
| 27/05/2022 | 92,28 | 93,11 | 91,75 | 93,08 | +0,83% | 1,47% | 9.802.000 |
| 26/05/2022 | 94,24 | 94,25 | 91,00 | 92,31 | -1,54% | 3,45% | 17.249.500 |
| 25/05/2022 | 94,36 | 94,76 | 93,14 | 93,75 | -0,94% | 1,72% | 11.177.700 |
| 24/05/2022 | 94,25 | 94,80 | 93,57 | 94,64 | +0,86% | 1,31% | 9.021.000 |
| 23/05/2022 | 93,59 | 94,92 | 93,40 | 93,83 | +0,30% | 1,62% | 9.067.000 |
| 20/05/2022 | 92,45 | 94,08 | 92,45 | 93,55 | +1,59% | 1,76% | 11.757.100 |
| 19/05/2022 | 91,25 | 92,61 | 90,88 | 92,09 | -0,01% | 1,90% | 11.121.600 |
| 18/05/2022 | 92,56 | 93,16 | 91,77 | 92,10 | -0,97% | 1,50% | 12.717.600 |
| 17/05/2022 | 92,31 | 94,56 | 91,51 | 93,00 | +0,74% | 3,30% | 17.582.800 |